You are here

Home

Research Projects

Aiming for hepatis C elimination - approaches to increasing engagement of people who inject drugs in hepatitis C testing, care and treatment.
In Australia hepatitis C infection predominately infects people who inject drugs. Direct acting antiviral therapy can cure the infection in around...
Supervisor: Professor Margaret Hellard
Barriers to hepatocellular carcinoma screening uptake
Hepatocellular carcinoma (HCC) is the sixth most common cancer and incidence is increasing worldwide, including in Australia. Currently, people with...
Supervisor: Dr Joseph Doyle
Carbapenem resistance in the Australian setting: using genomics to understand the spread of deadly pathogens
Multi-drug resistance in Gram-negative bacteria (MDR-GNB) is a global health challenge that threatens many medical advances. Infections caused by MDR...
Supervisor: Dr Nenad Macesic
Combating antimicrobial resistance through use of genomics and artificial intelligence
Antimicrobial resistance (AMR) is one of the most significant and immediate threats to health in Australia and globally. As an Infectious Diseases...
Supervisor: Dr Nenad Macesic
Data surveillance, modelling for hepatitis B elimination
Hepatitis B infection affects over 257 million people worldwide and is a major public health issue. Without timely treatment, chronic hepatitis B...
Supervisor: Dr Joseph Doyle
Eliminating hepatitis C infection in Australia through harm reduction, education and treatment scale up
Hepatitis C affects over 230,000 people in Australia. Currently only 1–2% of people with chronic HCV are treated annually. In 2016, the World Health...
Supervisor: Dr Joseph Doyle
Elimination of hepatitis C through rapid testing and treatment
Hepatitis C affects over 230,000 people in Australia. Currently only 1–2% of people with chronic HCV are treated annually. In 2016, the World Health...
Supervisor: Dr Joseph Doyle
Metabolic diversity of Klebsiella pneumoniae and association with ecological niche
Klebsiella pneumoniae is a ubiquitous bacterium that can inhabit a broad variety of host and environmental niches; from the human gut, to companion...
Supervisor: Dr Kelly Wyres
Metabolic modelling and nutrient utilisation of Klebsiella interspecies hybrids
BACKGROUND The threat of antimicrobial resistant pathogens is a growing and present danger in modern life. The Klebsiella pneumoniae species complex...
Supervisor: Dr Kelly Wyres
Perioperative carriage of antimicrobial resistant (AMR) organism and the development of surgical site infections in joint replacement surgery.
Over 2.4 million surgeries are performed annually in Australia and up to 15% of these procedures are complicated by infections involving the wound (...
Supervisor: Dr Trisha Peel
Predicting and reducing hepatitis C reinfection following treatment
The availability of new direct-acting antiviral (DAA) treatment for hepatitis C has led to global targets to eliminate the public health impact of...
Supervisor: Dr Joseph Doyle
Public health interventions to achieve hepatitis B elimination and reduce liver cancer
Hepatitis B infection affects over 257 million people worldwide and is a major public health issue. Without timely treatment, chronic hepatitis B...
Supervisor: Dr Joseph Doyle
Tackling superbugs: development of an integrated antimicrobial resistance infection prevention genomics service
Antimicrobial resistance (AMR) is an urgent global health challenge that threatens our healthcare system and many of the advances of modern medicine...
Supervisor: Dr Nenad Macesic
Understanding the changes in hospital patient movement flows due to COVID-19 and the effects on hospital acquired infections using network dynamics
During the COVID-19 epidemic in Victoria, many parts of the healthcare system were changed. Patient flows, such as which wards patients are admitted...
Supervisor: Dr Michael Lydeamore